Table 1.

Demographic and baseline characteristics

Characteristic	Cohort 1 (mefloquine; N = 23)	Cohort 2 (infectivity control; N = 6)
Gender
Male (n)	11 (47.8%)	3 (50%)
Female (n)	12 (52.2%)	3 (50%)
Age (years)
Mean (SD)	29.7 (6.8)	34.3 (9.9)
Median	28	35
Range	18–43	23–49
Body mass index
Mean (SD)	25.1 (5.3)	28.3 (5.3)
Median	24	27
Range	20–46	23–38
Race (n)
American Indian or Alaskan Native	1 (4.3%)	0 (0%)
Asian	1 (4.3%)	0 (0%)
Black or African American	7 (30.4%)	2 (33.3%)
White/Caucasian	13 (56.5%)	4 (66.7%)
Other	1 (4.3%)	0 (0%)
Ethnicity (n)
Non-Hispanic or Latino	22 (95.7%)	5 (83.3%)
Hispanic or Latino	1 (4.3%)	1 (16.7%)

SD = standard deviation.